IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Carisma Therapeutics Inc (CARM)

CUSIP: 14216R101 | NYSE | Healthcare · Biotechnology | Micro Cap | 118 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Union Bancaire Privee, UBP SA785
0.0% of portfolio›$0
Ascentis Independent Advisors200
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Union Bancaire Privee, UBP SA
785$00.0%GrowthMediumGeneva 1, Switzerland2026-11-04
Ascentis Independent Advisors
200$00.0%ETFLowDallas, TX2026-11-03